Navigation Links
Cephalon Announces Strong Third Quarter Financial Results
Date:11/8/2007

Other current assets 34,626 47,278

Total current assets 1,365,996 1,108,804

PROPERTY AND EQUIPMENT, net 481,508 453,010

GOODWILL 476,605 467,167

INTANGIBLE ASSETS, net 839,255 793,037

DEFERRED TAX ASSETS, net 103,284 118,192

OTHER ASSETS 132,056 105,287

$3,398,704 $3,045,497

CURRENT LIABILITIES:

Current portion of long-term debt $1,237,285 $1,023,312

Accounts payable 74,528 90,586

Accrued expenses 685,864 263,478

Total current liabilities 1,997,677 1,377,376

LONG-TERM DEBT 4,373 224,992

DEFERRED TAX LIABILITIES, net 66,864 72,491

OTHER LIABILITIES 103,982 61,178

Total liabilities 2,172,896 1,736,037

STOCKHOLDERS' EQUITY:

Common stock, $0.01 par value 693 678

Additional paid-in capital 1,899,761 1,780,749

Treasury stock, at cost (151,196) (151,068)

Accumulated deficit (668,310) (425,256)

Accumulated other comprehensive income 144,860 104,357

Total stockholders' equity 1,225,808 1,309,460

$3,398,704 $3,045,497

Certain reclassifications of prior year amounts have been made to conform to the current year presentation. The NUVIGIL(R) (armodafinil) [C-IV] i
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. Cephalon Quarterly Conference Call Invitation
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
8. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
9. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Understanding the need for better quality and higher ... that currently exists in this area, ChanTest has recently ... validated ion channel and GPCR cell lines. ChanTest’s ... channels control many critical physiological functions throughout the body. ... to treat a variety of human diseases. , ...
(Date:7/10/2014)... Angeles, CA (PRWEB) July 10, 2014 ... and Bioanalytical techniques during 18-20 August, 2014 at Double ... critically review the recent developments in Analytical & Bioanalytical ... the globe. , Speaking on this occasion, Dr. Srinubabu ... Analytica Acta conference is a remarkable one in ...
(Date:7/10/2014)... On July 9 Prime Minister ... Russia,s first national "Industry" award ... is developing a unique project called MabNext . ... number of innovative drugs based on monoclonal antibodies for ... place at the International Exhibition "Innoprom 2014" in Ekaterinburg. ...
(Date:7/10/2014)... 2014   Ceres, Inc . (Nasdaq: ... today financial results for the three months ended May ... Ceres reported that the company and its ... growing season in Brazil, which concluded in June, despite ... evaluation areas for part of the growing season. Yields ...
Breaking Biology Technology:Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 3A Critical Review of Analytical Techniques for Improved Living Standards 2A Critical Review of Analytical Techniques for Improved Living Standards 3A Critical Review of Analytical Techniques for Improved Living Standards 4Dmitry Medvedev Presented BIOCAD the First National "Industry" Award 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 3Ceres Announces Fiscal Third Quarter 2014 Financial Results 4Ceres Announces Fiscal Third Quarter 2014 Financial Results 5Ceres Announces Fiscal Third Quarter 2014 Financial Results 6Ceres Announces Fiscal Third Quarter 2014 Financial Results 7Ceres Announces Fiscal Third Quarter 2014 Financial Results 8Ceres Announces Fiscal Third Quarter 2014 Financial Results 9
... , SANTA CLARA, Calif., Dec. 7 Cell Biosciences, ... Inc. of Lexington, Massachusetts, a leader in sample preparation ... acquisition adds Protein Forest,s novel digital ProteomeChip(TM) product line ... protein analysis. , Protein Forest, founded in 2002, pioneered ...
... , , RESEARCH TRIANGLE PARK, N.C., ... innovative treatments for diseases of the central nervous system, today announced ... that CeNeRx,s novel compound TriRima (TM) reversibly inhibits MAO-A (monoamine ... role in the regulation of mood. TriRima is ...
... ... Pollogen received ANVISA approval to market the TriPollar Technology- the most advanced ... anti-aging products have been clinically proven the world over to be ... and non-invasive and patients enjoy visible results from the very 1st treatment. ...
Cached Biology Technology:Cell Biosciences Acquires Protein Forest 2Publication in Neuropsychopharmacology Confirms CeNeRx's Novel RIMA Antidepressant TriRima(TM) Selectively and Reversibly Inhibits MAO-A 2Publication in Neuropsychopharmacology Confirms CeNeRx's Novel RIMA Antidepressant TriRima(TM) Selectively and Reversibly Inhibits MAO-A 3Publication in Neuropsychopharmacology Confirms CeNeRx's Novel RIMA Antidepressant TriRima(TM) Selectively and Reversibly Inhibits MAO-A 4Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 2Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 3
(Date:7/11/2014)... the National Institute of Standards and Technology (NIST) ... more effectively, they often prove that necessity is ... case recently for M. Lorna De Leoz and ... specialization of glycomics. Glycomics is the study of ... are attached to proteins and lipids and influence ...
(Date:7/11/2014)... members to reduce aggression and gain access to scarce ... activities shows a certain pattern across the day. The ... Biology Letters . , Grooming between individuals in a ... To be groomed has hygienic benefits and is stress ... provide access to infants, mating opportunities and high quality ...
(Date:7/11/2014)... Researchers have pioneered a revolutionary new way ... called Virtual Finger, allows scientists to move through ... synapses using the flat surface of their computer ... studies orders of magnitude more efficient, saving time, ... many areas of experimental biology. The software and ...
Breaking Biology News(10 mins):Baboons groom early in the day to get benefits later 2Virtual finger enables scientists to navigate and analyze complex 3D images 2
... was the credo of early 20th century architects making design ... biologists may be turning that on its head. New research* ... and Technology (NIST) reinforces the idea that stem cells can ... by controlling their shape. The results may be important to ...
... of Health (NIH) has awarded a five-year $23.2 million ... and the University of Medicine and Dentistry of New ... research aimed at developing drug products that could be ... Members of the Environmental and Occupational Health Sciences ...
... A protein critical in heart development may also play ... by investigators from Vanderbilt-Ingram Cancer Center and the Vanderbilt Eye ... which also is key in regulating corneal cells ... , The study, appearing in the October issue of ...
Cached Biology News:Shaping up: Controlling a stem cell's form can determine its fate 2Rutgers, UMDNJ receive $23 million to develop antidotes for chemical weapons attacks 2Protein found in heart may be target for colon cancer therapies 2Protein found in heart may be target for colon cancer therapies 3
Handles samples from from 75l to 150l...
Hybridization chamblers suitable for use with all ChIP-GLAS microarrays....
Ubiquitin Related I Sampler Kit 10 mu g each...
DNA Repair Sampler Kit 10g each...
Biology Products: